|Last Price$13.65||Day Change (%)1.34%|
|Open Price$13.48||Day Change ($)0.18|
|Day Range13.43–13.71||52-Week Range7.07–14.08|
As of Thu 04/17/2014 04:14 PM EST | USD
Boston Scientific Begins Expansion of The S-ICD™ System in Asia
Boston Scientific Introduces the Expect™ Slimline (SL) Needle for Use During Endoscopic Ultrasound Fine Needle Aspiration Procedures
Boston Scientific Reports Key Data At ACC 2014 For Cardiac Resynchronization Therapy Technology, Platinum Chromium Stents And Lotus™ Valve System
New Long-term Data Demonstrate Patients with Mild Heart Failure Sustained Lower Mortality Rates After Receiving Boston Scientific CRT Defibrillators
Research and Markets: Global Endoscopy Equipment Market Forecasts & Opportunities 2014-2018: Endoscopes, Visualization Systems & Application
A handful of health-care names are selling at premiums now, but buying opportunities are surfacing, as well.
Week ending August 4
The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.
Following is a roundup of stocks that recently jumped to 5 stars. By way of background, we award a stock 5 stars when it trades at a suitably large discount--i.e., a margin of safety--to our fair value estimate. Thus, when a stock hits 5-star territory, we consider it an especially compelling ...
Med-tech multinationals look to the East for growth in China.